| Name | Pharmerica |
|---|---|
| Organization Name | Pharmacy Corporation Of America |
| Location | 5255 E River Rd, Ste 204, Fridley, Minnesota 55421 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (763) 571-2220 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Researchers at the Morgridge Institute for Research believe they have identified a weak spot in the replication process of positive-strand RNA viruses, which could yield treatment for viral infections such as Zika, Polio, Chikungunya, Hepatitis C and even common cold viruses.
› Verified 4 days ago
| NPI Number | 1285667865 |
| Organization Name | PHARMACY CORPORATION OF AMERICA |
| Doing Business As | PHARMERICA |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 5255 E River Rd, Suite 204, Fridley, MN 55421 |
| Phone Number | 763-571-2220 |
News Archive
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Researchers at the Morgridge Institute for Research believe they have identified a weak spot in the replication process of positive-strand RNA viruses, which could yield treatment for viral infections such as Zika, Polio, Chikungunya, Hepatitis C and even common cold viruses.
› Verified 4 days ago
News Archive
A new combination of investigational drugs successfully suppressed hepatitis C genotype 1 infection in a high percent of patients who had not responded to previous treatment in a study led by a University of Michigan hepatologist.
An outpatient clinic founded on evidence-based treatments has opened at the Center for Neurobehavioral Research on Addictions (CNRA) at The University of Texas Health Science Center at Houston.
Zacharon Pharmaceuticals, Inc. today announced that the company has entered into a strategic research collaboration with Pfizer Inc. to develop drugs for orphan diseases, including lysosomal storage disorders. The potential value of the collaboration to Zacharon is approximately USD $210 million. The collaboration includes the potential development of compounds that may be discovered using Zacharon's innovative platform for developing small molecule drugs targeting specific carbohydrate polymers or glycans.
Antiretroviral therapy (ART) programs for treating HIV in developing countries are about as effective as ART programs in developed countries, according to an article in the July 15 issue of Clinical Infectious Diseases, now available online.
Researchers at the Morgridge Institute for Research believe they have identified a weak spot in the replication process of positive-strand RNA viruses, which could yield treatment for viral infections such as Zika, Polio, Chikungunya, Hepatitis C and even common cold viruses.
› Verified 4 days ago
Cvs Pharmacy #08435 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5696 University Ave, Fridley, Minnesota 55432 Phone: (763) 571-2081 | |
Cvs Pharmacy #17278 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 755 53rd Ave Ne, Fridley, Minnesota 55421 Phone: (763) 571-9766 | |
Walgreens #4697 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6525 University Ave Ne, Fridley, Minnesota 55432 Phone: (763) 586-0730 | |
Wal-mart Pharmacy 10-1952 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8450 University Ave Ne, Fridley, Minnesota 55432 Phone: (763) 780-9500 | |
Cub Pharmacy #1630/712 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 246 57th Ave Ne, Fridley, Minnesota 55432 Phone: (763) 586-9150 |